Appointment(s)
Senior Consultant, Division of Rheumatology, Department of Medicine, National University Hospital
Vice-Dean (Education), Yong Loo Lin School of Medicine, National University of Singapore
Group Director Education Office, National University Health System
Degree(s)
MBBS, National University of Singapore (Singapore) 1991
Master of Medicine (Internal Medicine, NUS) 1997
Membership Royal College of Physicians (UK), 1997
Fellow of Academy of Medicine, Singapore (Rheumatology) 2002
Master of Medical Science in Clinical Epidemiology (University of Newcastle, Australia) 2003
Fellow of the Royal College of Physicians (Edinburgh) 2004
Graduate Diploma in Acupuncture (MOH accredited) 2007
Doctor of Philosophy in School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine (University of Newcastle, Australia) 2020
Biography
Adjunct Professor Lau Tang Ching is a Senior Consultant Rheumatologist in the Division of Rheumatology, Department of Medicine in the National University Hospital. He has been appointed as the Vice-Dean (Education) of NUS Yong Loo Lin School of Medicine in June 2017 and Group Director of the National University Health System Education Office in February 2018. He graduated in 1991 from the National University of Singapore and obtained his Membership of the Royal College of Physician in United Kingdom and the Master of Medicine (internal medicine) degree in 1997. He is a fellow of the Academy of Medicine Singapore since 2001.
He also holds both a Master of Medical Science degree in Clinical Epidemiology and a Doctor of Philosophy in School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine (University of Newcastle, Australia), a fellow of the Royal College of Physicians (Edinburgh) and a Graduate Diploma in Acupuncture (Singapore).
His main research interests are in Osteoporosis, Pharmacoeconomic Evaluation, Medical Education and Evidence Based Medicine. He has helped to coordinate the Health Service Development Program for osteoporosis (HSDP) in 2003 to 2007 in the NHG cluster, which was successful in improving adherence and reducing the recurrent fracture rates of patients who were at high risk of recurrent fractures. He is helping to coordinate the Osteoporosis Disease Management Program (OPTIMAL), which is an extension of the previous HSDP osteoporosis program.
